Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation Research

• Publication date

  2001-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HH1701.095642PMID 11532900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The genetic basis of common diseases.

  2002cited by this paper
• Antibodies to Human Heat-Shock Protein 60 Are Associated With the Presence and Severity of Coronary Artery Disease: Evidence for an Autoimmune Component of Atherogenesis

  2001cited by this paper
• Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?

  2001cited by this paper
• Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

  2001cited by this paper
• NF‐κB‐dependent fractalkine induction in rat aortic endothelial cells stimulated by IL‐1β, TNF‐α, and LPS

  2000cited by this paper
• Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease

  2000cited by this paper
• Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

  2000cited by this paper
• Autoantibodies to modified LDLs and other phospholipid–protein complexes as markers of cardiovascular diseases

  2000cited by this paper
• Genetic polymorphism in CX3CR1 and risk of HIV disease.

  2000cited by this paper
• Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

  2000cited by this paper
• Participation of innate and acquired immunity in atherosclerosis

  2000cited by this paper
• Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

  2000cited by this paper
• International union of pharmacology. XXII. Nomenclature for chemokine receptors.

  2000cited by this paper
• The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis.

  2000cited by this paper
• Fractalkine-Mediated Endothelial Cell Injury by NK Cells1

  2000cited by this paper
• CX3C-Chemokine, Fractalkine-Enhanced Adhesion of THP-1 Cells to Endothelial Cells Through Integrin-Dependent and -Independent Mechanisms1

  2000cited by this paper
• Chemokines, leukocytes, and atherosclerosis.

  2000cited by this paper
• Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice

  2000cited by this paper
• NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS.

  2000cited by this paper
• Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition.

  2000cited by this paper
• Relation of inflammation to vascular function in patients with coronary heart disease.

  2000cited by this paper
• Novel risk factors for atherosclerosis.

  2000cited by this paper
• Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites.

  1999cited by this paper
• Infection and atherosclerosis: emerging mechanistic paradigms.

  1999cited by this paper
• Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction

  1999cited by this paper
• Does Chlamydia pneumoniae cause atherosclerosis?

  1999cited by this paper
• Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

  1999cited by this paper
• Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.

  1999cited by this paper
• Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart

  1999cited by this paper
• Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans

  1999cited by this paper
• Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function.

  1999cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

  1998cited by this paper
• Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction.

  1998cited by this paper
• Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.

  1998cited by this paper
• Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction.

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.

  1997cited by this paper
• A new class of membrane-bound chemokine with a CX3C motif

  1997cited by this paper
• Nitric oxide activity in the atherosclerotic human coronary circulation.

  1997cited by this paper
• Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion

  1997cited by this paper
• Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

  1997cited by this paper
• Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk

  1997cited by this paper
• Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.

  1997cited by this paper
• Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

  1996cited by this paper
• A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

  1996cited by this paper
• Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

  1995cited by this paper
• Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.

  1995cited by this paper
• Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited.

  1994cited by this paper
• Genetic susceptibility to death from coronary heart disease in a study of twins.

  1994cited by this paper
• Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).

  1993cited by this paper
• The Genetic Basis of Common Diseases

  1993cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.

  1990cited by this paper

• Chemokine receptors in GtoPdb v.2025.3

  2025cites this paper
• Chemokine receptors in GtoPdb v.2025.1

  2025cites this paper
• Pathogenic and clinical significance of inflammation-associated MicroRNAs in cardiovascular diseases

  2025cites this paper
• Differential influence of 1,8-Cineol on distinct hypoxia-related immune alterations in human monocytes

  2025cites this paper
• Improved levels of checkpoint molecule PD‐L1 on peripheral blood monocyte subsets in obstructive sleep apnea syndrome patients upon hypoglossal nerve stimulation

  2024cites this paper
• Obesity-related Plasma CXCL10 Drives CX3CR1-dependent Monocytic Secretion of Macrophage Migration Inhibitory Factor

  2024cites this paper
• Targeting immune cell recruitment in atherosclerosis

  2024cites this paper
• Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV

  2024cites this paper
• A Comprehensive Genetic and Bioinformatic Analysis Provides Evidence for the Engagement of COVID-19 GWAS-Significant Loci in the Molecular Mechanisms of Coronary Artery Disease and Stroke

  2024cites this paper
• Different Influence Pattern of Conventional and Alternative Sources of Smoking on Adhesion Molecules and Cytokine Secretion in THP-1 Monocytes

  2024cites this paper
• Progression of radio-labeled molecular imaging probes targeting chemokine receptors.

  2024cites this paper
• Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11

  2024cites this paper
• Distinguishing the impact of distinct obstructive sleep apnea syndrome (OSAS) and obesity related factors on human monocyte subsets

  2024cites this paper
• Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer

  2023cites this paper
• Differential Effects of Anti-PD-1/PD-L1 Checkpoint Inhibitors on Adhesion Molecules and Cytokine Secretion by THP-1 Monocytes

  2023cites this paper
• Fractalkine/CX3CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?

  2023cites this paper
• Plasma Leptin Levels, Obstructive Sleep Apnea Syndrome, and Diabetes Are Associated with Obesity-Related Alterations of Peripheral Blood Monocyte Subsets

  2023cites this paper
• Chemokine receptors in GtoPdb v.2023.1 Chemokine receptors in GtoPdb v.2023.1

  2023cites this paper
• Smoking-, Alcohol-, and Age-Related Alterations of Blood Monocyte Subsets and Circulating CD4/CD8 T Cells in Head and Neck Cancer

  2022cites this paper
• Digital spatial profiling of coronary plaques from persons living with HIV reveals high levels of STING and CD163 in macrophage enriched regions

  2020cites this paper
• Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury

  2020cites this paper
• Cytomegalovirus Coinfection Is Associated with Increased Vascular-Homing CD57+ CD4 T Cells in HIV Infection

  2020cites this paper
• CX3CL1 and IL-15 Promote CD8 T cell chemoattraction in HIV and in atherosclerosis

  2020cites this paper
• Depression and Cardiovascular Disease: The Viewpoint of Platelets

  2020influential citation
• Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications.

  2020cites this paper
• Chemokine receptors (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Chemokine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Lack of Fractalkine Receptor on Macrophages Impairs Spontaneous Recovery of Ribbon Synapses After Moderate Noise Trauma in C57BL/6 Mice

  2019cites this paper
• Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury

  2018cites this paper
• CX3CR1/CX3CL1 Axis Mediates Platelet–Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis

  2018cites this paper
• The homozygous CX3CR1-M280 mutation impairs human monocyte survival.

  2018cites this paper
• RANK ligand and the regulation of skeletal remodeling

  2018cites this paper
• The homozygous CX 3 CR 1M 280 mutation impairs human monocyte survival

  2018cites this paper
• CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi

  2018cites this paper
• Downregulation of CX3CR1 ameliorates experimental colitis: evidence for CX3CL1-CX3CR1-mediated immune cell recruitment

  2017cites this paper
• Opposite effects of CX3CR1 receptor polymorphismsV249I andT280Mon the development of acute coronary syndrome A possible implication of fractalkine in inflammatory activation

  2017influential citation
• Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers

  2017cites this paper
• Association of V249I and T280M variants of fractalkine receptor CX3CR1 with carotid intima-media thickness in a mexican population with type 2 diabetes.

  2017cites this paper
• Chemokines in atherosclerosis 715 Endothelial dysfunction triggers migration of inflammatory cells

  2017cites this paper
• PSGL-1-MEDIATED ADHESION AND CHEMOKNE-MEDIATED MGRATION WITH PSGL-1-SPECIFIC ANTIBODES

  2017cites this paper
• Investigating the link between MCP-1 A-2518G, RANTES G-403A, CX3CR1 V249I and MTHFR C677T gene polymorphisms and the risk of acute myocardial infarction among Egyptians

  2017cites this paper
• Association of V 249 I and T 280 M variants of fractalkine receptor CX 3 CR 1 with carotid intima-media thickness in a Mexican population with type 2 diabetes

  2017cites this paper
• Elucidating the Regulation of ADAM17 Mediated Shedding of CX3CL1 from Vascular Endothelial Cells

  2017cites this paper
• Synergistic Modulation of Inflammatory but not Metabolic Effects of High-Fat Feeding by CCR2 and CX3CR1

  2017cites this paper
• Common and Rare Genetic Variation in CCR2, CCR5, or CX3CR1 and Risk of Atherosclerotic Coronary Heart Disease and Glucometabolic Traits

  2016cites this paper
• Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion Mechanism.

  2016cites this paper
• Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease

  2016cites this paper
• Role of CX3CL1 in Diseases

  2016cites this paper
• Inflammatory Function of CX3CR1+ CD8+ T Cells in Treated HIV Infection Is Modulated by Platelet Interactions.

  2016cites this paper
• TLR4-dependent internalization of CX3CR1 aggravates sepsis-induced immunoparalysis.

  2016cites this paper
• A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.

  2015cites this paper
• The Neurorepellent Slit2 Inhibits Postadhesion Stabilization of Monocytes Tethered to Vascular Endothelial Cells

  2015cites this paper
• Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis

  2015cites this paper
• Disfunción endotelial en territorio arterial en pacientes jóvenes con enfermedad tromboembólica venosa

  2015cites this paper
• Etude du signal AMP cyclique déclenché par la chimiokine CX3CL1 en aval de son récepteur CX3CR1

  2015cites this paper
• Modulation of platelet and monocyte function by the chemokine fractalkine (CX3CL1) in cardiovascular disease

  2015cites this paper
• Role of Fractalkine / CX 3 CL 1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies

  2015cites this paper
• Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina

  2015cites this paper
• Effects on Serum Fractalkine by Diet and Omega-3 Fatty Acid Intervention: Relation to Clinical Outcome

  2015cites this paper
• Nonsynonymous T280M gene variant of CX3CR1 in South Indian population is associated with reduced risk for vascular disease in patients with diabetes mellitus

  2015influential citation
• Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.

  2015cites this paper
• Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression.

  2015cites this paper
• Association of CX3CR1 (V249I and T280M) polymorphisms with age-related macular degeneration: a meta-analysis.

  2015cites this paper
• Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients

  2014cites this paper
• The effect of testosterone on factors associated with diabetes, atherosclerosis and obesity.

  2014cites this paper
• Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies

  2014cites this paper
• Interaction of chemokines with their receptors--from initial chemokine binding to receptor activating steps.

  2014cites this paper
• Circulating Fractalkine Levels Predict the Development of the Metabolic Syndrome

  2014cites this paper
• Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease

  2014cites this paper
• Identification of Pathways Associated With Endothelial Dysfunction in Obesity

  2014cites this paper
• An investigation of the prognostic utility of RANTES levels in predicting mortality in an angiography population

  2014cites this paper
• Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis

  2014cites this paper
• Chemokines in Atherosclerosis: Proceedings Resumed

  2014cites this paper
• Two Polymorphisms in the Fractalkine Receptor CX3CR1 Gene Influence the Development of Atherosclerosis: A Meta-Analysis

  2014cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cites this paper
• The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

  2013cites this paper
• Chemokines and atherosclerosis : focus on the CX 3 CL 1 / CX 3 CR 1 pathway

  2013cites this paper
• Regulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation

  2013cites this paper
• This information is current as Inflammation Fractalkine Receptor during Autoimmune Regulation of Adaptive Immunity by the

  2013cites this paper
• Pharmacological Inhibition of the Chemokine Receptor, CX3CR1, Reduces Atherosclerosis in Mice

  2013cites this paper
• Antigen-independent pathogenic and protective immunity in chronic neuroinflammation

  2013cites this paper
• Die Rolle und Funktionsweise der Chemokinrezeptoren CXCR4 und CXCR7 in Mikroglia und Astrozyten

  2013cites this paper
• CX3CR1 Receptor Polymorphisms, Th1 Cell Recruitment, and Acute Myocardial Infarction Outcome: Looking for a Link

  2013cites this paper
• The polymorphisms of chemokine gene in channel catfish (Ictalurus punctatus) and the associations with susceptibility/resistance to Edwardsiella ictaluri

  2013cites this paper
• Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway

  2013cites this paper
• A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study

  2013cites this paper
• Regulation of Atherogenesis by Chemokines and Chemokine Receptors

  2013cites this paper
• CX3CL1-mediated cell-cell adhesion constitutive cleavage of CX3CL1 (fractalkine) and regulates The disintegrin-like metalloproteinase ADAM10 is involved in

  2013cites this paper
• Association of V249I and T280M Polymorphisms in the Chemokine Receptor CX3CR1 Gene with Early Onset of Coronary Artery Disease Among North Indians

  2012cites this paper
• Touch of Chemokines

  2012cites this paper
• The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.

  2012influential citation
• Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1

  2012cites this paper
• Genetic Variants in Platelet Factor 4 Modulate Inflammatory and Platelet Activation Biomarkers

  2012cites this paper
• Association of Sequence Variation in the CX3CR1 Gene with Geographic Atrophy Age-related Macular Degeneration in a Greek Population

  2012cites this paper
• Lysophosphatidic acid : role in CXCL12-mediated vascular repair and atherogenic monocyte recruitment

  2012cites this paper
• An association study between polymorphisms of the fractalkine receptor gene, CX3CR1, and cerebral infarction in the Han Chinese population.

  2012cites this paper
• Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium

  2012cites this paper
• Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.

  2012cites this paper
• Fractalkine – a local inflammatory marker aggravating platelet activation at the vulnerable plaque

  2012cites this paper